Open access chemoinformatics to tackle antimicrobial resistance

As part of MedChemNet’s focus on antimicrobial drug discovery, CO-ADD's Johannes Zuegg discusses how we tackle the growing problem of drug resistance through providing a free screening platform for chemists, and how big data will be increasingly valuable in the battle against antimicrobial resistance in the next 5-10 years.

> Read more

Share this post